A recent report released by Oncolytics Biotech Inc. indicated that the precision oncology market experienced a significant growth, reaching $139.4 billion in 2025. The market is projected to continue its upward trend, with estimations foreseeing it to soar to $317.5 billion by the year 2035. This surge has been attributed to a notable transformation in cancer treatment strategies, emphasizing the importance of precision medicine in combating the disease.